|
|
Volumn 4, Issue 2, 2002, Pages 177-180
|
|
Use of selected CD34+ cells in the treatment of relapsed/progressive HD: Experiences from a single center
a
|
|
Author keywords
Complete remission; Hodgkin's disease
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARMUSTINE;
CD34 ANTIGEN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DACARBAZINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
MELPHALAN;
METHOTREXATE;
PREDNISONE;
VINBLASTINE;
ADOLESCENT;
ADULT;
ALLOTRANSPLANTATION;
APHERESIS;
ARTICLE;
AUTOGRAFT;
AUTOTRANSPLANTATION;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURVIVAL;
CELL SELECTION;
CLINICAL ARTICLE;
DRUG MEGADOSE;
EXPERIENCE;
FEMALE;
FOLLOW UP;
HODGKIN DISEASE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MALE;
MORTALITY;
PERIPHERAL BLOOD STEM CELL;
RECURRENT CANCER;
SAFETY;
STEM CELL TRANSPLANTATION;
TOXICITY;
CLINICAL TRIAL;
HEMATOPOIETIC STEM CELL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
IMMUNOLOGY;
MIDDLE AGED;
ADULT;
ANTIGENS, CD34;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HODGKIN DISEASE;
HUMANS;
MALE;
MIDDLE AGED;
TRANSPLANTATION, AUTOLOGOUS;
|
|
EID: 0036000606
PISSN: 14653249
EISSN: None
Source Type: Journal
DOI: 10.1080/146532402317381884 Document Type: Article |
|
Times cited : (3)
|
|
References (8)
|
